[HTML][HTML] Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
M Karimi-Zarchi, L Allahqoli, A Nehmati, AM Kashi… - BMC Public Health, 2020 - Springer
Background Human papillomavirus (HPV) is one of the most significant risk factors for
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial.
M Karimi-Zarchi, L Allahqoli, A Nehmati… - BMC public …, 2020 - eprints.ssu.ac.ir
BACKGROUND Human papillomavirus (HPV) is one of the most significant risk factors for
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
M Karimi-Zarchi, L Allahqoli, A Nehmati, AM Kashi… - BMC Public …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Human papillomavirus (HPV) is one of the most significant risk factors for cervical cancer …
Human papillomavirus (HPV) is one of the most significant risk factors for cervical cancer …
Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
M Karimi-Zarchi, L Allahqoli, A Nehmati, AM Kashi… - 2020 - pubmed.ncbi.nlm.nih.gov
Background Human papillomavirus (HPV) is one of the most significant risk factors for
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
M Karimi-Zarchi, L Allahqoli, A Nehmati… - BMC Public …, 2020 - search.proquest.com
Background Human papillomavirus (HPV) is one of the most significant risk factors for
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
[引用][C] Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
M Karimi-Zarchi, L Allahqoli, A Nehmati… - BMC Public Health …, 2020 - jglobal.jst.go.jp
Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women
with CIN? A randomized trial | Article Information | J-GLOBAL Art J-GLOBAL ID:202002243830268937 …
with CIN? A randomized trial | Article Information | J-GLOBAL Art J-GLOBAL ID:202002243830268937 …
[PDF][PDF] Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
M Karimi-Zarchi, L Allahqoli, A Nehmati, AM Kashi… - 2020 - academia.edu
Background: Human papillomavirus (HPV) is one of the most significant risk factors for
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial.
M Karimi-Zarchi, L Allahqoli, A Nehmati, AM Kashi… - 2020 - cabidigitallibrary.org
Background: Human papillomavirus (HPV) is one of the most significant risk factors for
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
[HTML][HTML] Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
M Karimi-Zarchi, L Allahqoli, A Nehmati… - BMC Public …, 2020 - ncbi.nlm.nih.gov
Background Human papillomavirus (HPV) is one of the most significant risk factors for
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial.
M Karimi-Zarchi, L Allahqoli, A Nehmati… - BMC Public …, 2020 - europepmc.org
Background Human papillomavirus (HPV) is one of the most significant risk factors for
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …
cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical …